Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase 2a randomized clinical trial of dupilumab (anti‐IL‐4Rα) for alopecia areata patients

Published:2021-09-06 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Guttman‐Yassky Emma¹^ORCID,Renert‐Yuval Yael¹²^ORCID,Bares Jennifer¹,Chima Margot¹,Hawkes Jason E.³,Gilleaudeau Patricia²,Sullivan‐Whalen Mary²,Singer Giselle K.¹,Garcet Sandra²,Pavel Ana B.⁴^ORCID,Lebwohl Mark G.¹^ORCID,Krueger James G.²

Affiliation:

1. Department of Dermatology Icahn School of Medicine at Mount Sinai New York NY USA

2. Laboratory for Investigative Dermatology Rockefeller University New York NY USA

3. Department of Dermatology UC Davis Medical Center University of California Davis Health System Sacramento CA USA

4. Department of Biomedical Engineering University of Mississippi Oxford MS USA

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15071

Reference37 articles.

1. Lifetime Incidence Risk of Alopecia Areata Estimated at 2.1% by Rochester Epidemiology Project, 1990–2009

2. Alopecia areata: A long term follow-up study of 191 patients

3. Subcutaneous efalizumab is not effective in the treatment of alopecia areata

4. Association Between Alopecia Areata, Anxiety, and Depression: A Systematic Review and Meta-analysis

5. Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hair regrowth in alopecia areata and re‐pigmentation in vitiligo in response to treatment: Commonalities and differences;Journal of the European Academy of Dermatology and Venereology;2024-09-11

2. Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata;American Journal of Clinical Dermatology;2024-09-03

3. Recent approaches of antibody therapeutics in androgenetic alopecia;Frontiers in Pharmacology;2024-08-16

4. Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds;Allergy;2024-08-08

5. 735 - A case series of dupilumab for vitiligo and alopecia areata in the setting of AD;British Journal of Dermatology;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3